Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The purpose of this study is to learn how best to treat substance use disorders in an HIV clinic setting. Specifically, the purpose of this pilot study is to learn if extended-release naltrexone (XR-NTX) would be a feasible and acceptable treatment for HIV-infected individuals with opioid or alcohol use disorders.
Epistemonikos ID: 820953308e32ae55dad8ea8c8801ff7b25dbe53b
First added on: Mar 27, 2024